New Delhi: An expert panel of the Indian government is in discussion with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday. 
While Speaking in the Lok Sabha,  the Union health minister said, "Prime Minister has said many times not to politicise vaccination programme. It is our aim to vaccinate every citizen above 18 years of age in the country. This is not the time to do politics. An expert group of the Indian government is still in talks with Pfizer over Covid vaccine supply."

Dr Bharati Pravin Pawar, minister of state, health ministry said, "A total of Rs 9,725.15 crore have been spent so far on the Covid-19 vaccination programme including procurement of vaccines and operational cost for vaccination. A total of 135 crore doses of Covid-19 vaccine are expected to be available between August 2021 to December 2021." He also  said advance payments have been made to domestic manufacturers of Covid-19 vaccines so that no delay in procurement arises. He added that "There has been no delay in entering into purchase agreements with the domestic vaccine manufacturers. Advance payments have also been made to manufacturers for the supply orders placed with them." 

Every Congress worker is now party president, says Navjot Sidhu as PPCC chief

Delhi High Court orders Kejriwal govt to pay rents for poor tenants

TMC MP Shantanu Sen suspended for entire monsoon session for tearing necessary papers in Parliament